Fetal Maceration

Fetal maceration is a pathological condition of pregnancy characterized by the aseptic or septic disintegration and liquefaction of a dead fetus within the uterus, typically occurring after fetal death but before the onset of parturition. The process involves enzymatic autolysis and bacterial putrefaction, leading to the breakdown of fetal soft tissues, leaving only skeletal remains. This condition is most commonly observed in bitches and queens, but can occur in other domestic species. Fetal maceration is distinct from fetal mummification, where the fetus undergoes dehydration and becomes leathery without bacterial decomposition. Maceration is often associated with uterine infection, as the presence of bacteria accelerates tissue breakdown and leads to the accumulation of purulent or sanguinopurulent exudate. The condition may be complete, where all fetal tissues are liquefied, or incomplete, where some fetal parts remain. Clinically, fetal maceration can result in chronic endometritis, pyometra, or systemic illness if the uterine contents become infected and toxins are absorbed. The condition is a significant cause of infertility and reproductive failure in breeding animals.

The primary etiology of fetal maceration is fetal death in utero, which can result from a variety of causes including infectious agents (e.g., Brucella canis, Streptococcus spp., Escherichia coli, canine herpesvirus, feline herpesvirus, feline leukemia virus), hormonal imbalances (e.g., luteal insufficiency, progesterone deficiency), placental insufficiency, trauma, genetic abnormalities, and environmental stressors. Infectious agents are the most common triggers, as they can cause placentitis, fetal sepsis, and subsequent fetal death. Bacterial colonization of the uterus, often ascending from the vagina, leads to putrefaction of the dead fetus. In bitches, Brucella canis is a classic cause of late-term abortion and fetal maceration. In queens, feline herpesvirus and feline panleukopenia virus are significant viral causes. Additionally, maternal systemic diseases such as diabetes mellitus, hypothyroidism, or renal disease can compromise fetal viability. Iatrogenic causes include improper administration of abortifacient drugs or trauma during pregnancy diagnosis. The presence of a foreign body or uterine torsion can also lead to fetal death and subsequent maceration. The exact mechanism involves the release of proteolytic enzymes from fetal tissues and bacteria, which liquefy the fetal soft tissues, leaving bones that may be retained in the uterus.

Fetal maceration is relatively uncommon but is more frequently diagnosed in dogs and cats than in other domestic species. In dogs, it is often associated with Brucella canis infection, particularly in breeding kennels with poor biosecurity. The condition can occur in any breed, but there may be a higher incidence in breeds with a predisposition to dystocia or uterine inertia, such as brachycephalic breeds. Age and parity are not strong risk factors, but older females with a history of reproductive problems may be at increased risk. In cats, fetal maceration is often seen in feral or free-roaming populations with higher exposure to infectious agents. The incidence is higher in animals that have experienced previous pregnancy loss or have uterine abnormalities such as cystic endometrial hyperplasia. Seasonality may play a role in regions with seasonal breeding, as infections like brucellosis may peak during breeding seasons. Overall, the condition is sporadic, but in endemic areas of brucellosis, the incidence can be significant. Early diagnosis and management are crucial to prevent complications such as pyometra and sepsis.

The pathophysiology of fetal maceration begins with fetal death, which can be caused by infectious, hormonal, or mechanical factors. Once fetal death occurs, the corpus luteum may persist, maintaining progesterone levels and preventing the onset of parturition. The dead fetus remains in the uterus, and if bacteria are present, they proliferate and produce enzymes that cause liquefactive necrosis of fetal tissues. The uterine environment becomes anaerobic, favoring the growth of anaerobes such as Bacteroides and Fusobacterium species. The inflammatory response leads to the accumulation of neutrophils and macrophages, which release additional proteolytic enzymes. The fetal skeleton, being more resistant to enzymatic degradation, remains intact. The uterine wall becomes thickened and inflamed, and the cervix may remain closed, trapping the necrotic material. Over time, the uterine contents become a mixture of purulent exudate and fetal bones. If the cervix opens, the exudate may drain vaginally, leading to a characteristic discharge. Systemic absorption of toxins and bacteria can cause endotoxemia and sepsis, leading to fever, depression, and potentially death. The condition can also lead to uterine rupture and peritonitis if the uterine wall becomes necrotic.

Predisposing factors for fetal maceration include infectious diseases, particularly brucellosis in dogs and viral infections in cats. Poor hygiene during breeding or whelping can introduce bacteria into the reproductive tract. Hormonal imbalances, such as luteal insufficiency or progesterone deficiency, can lead to fetal death. Uterine abnormalities, including cystic endometrial hyperplasia, uterine torsion, or uterine inertia, can predispose to fetal retention. Trauma to the abdomen during pregnancy can cause fetal death. Genetic abnormalities in the fetus may also be a factor. Environmental stressors, such as overcrowding, poor nutrition, and extreme temperatures, can compromise fetal viability. Iatrogenic factors include improper use of abortifacient drugs or corticosteroids. Additionally, maternal age and parity may play a role, with older females or those with a history of dystocia being at higher risk. Breed-specific factors, such as brachycephalic conformation, can increase the risk of dystocia and subsequent fetal death.

Clinical signs of fetal maceration may vary depending on the stage and severity. In the early stages, there may be no obvious signs, and the condition may be detected incidentally during pregnancy ultrasound. As the condition progresses, the most common sign is a vaginal discharge, which may be sanguinopurulent, mucopurulent, or brownish, often with a foul odor. The discharge may be intermittent and may contain fetal bones. The female may show signs of systemic illness, including fever, lethargy, anorexia, and depression. Abdominal palpation may reveal an enlarged uterus with firm masses (fetal bones). In some cases, the cervix may be open, allowing the discharge to be seen. If the condition is associated with pyometra, there may be polydipsia, polyuria, and vomiting. In severe cases, signs of sepsis, such as tachycardia, tachypnea, and pale mucous membranes, may be present. The female may also exhibit signs of abdominal pain, such as restlessness or a hunched posture. In chronic cases, the animal may present with infertility or failure to conceive in subsequent cycles.

Differential diagnoses for fetal maceration include: 1) Fetal mummification: In mummification, the fetus is dehydrated and becomes leathery, without bacterial decomposition, and there is usually no foul-smelling discharge. 2) Pyometra: Pyometra is characterized by a purulent uterine infection, often with a closed cervix, and may be associated with cystic endometrial hyperplasia. Ultrasound may show a fluid-filled uterus without fetal remnants. 3) Abortion: Abortion involves the expulsion of a dead fetus before term, and the fetus may be expelled intact or partially autolyzed. 4) Dystocia: Dystocia is difficult parturition, and fetal death may occur during labor, but the fetus is usually expelled with assistance. 5) Metritis: Metritis is inflammation of the uterine wall, often postpartum, and may be associated with retained fetal membranes. 6) Uterine torsion: Uterine torsion can cause fetal death and may present with acute abdominal pain and shock. 7) Vaginal foreign body: A foreign body in the vagina can cause discharge and may be mistaken for fetal remnants. 8) Neoplasia: Uterine or vaginal tumors can cause discharge and abdominal masses. 9) Pregnancy with fetal death: A dead fetus without maceration may be retained, but without the characteristic liquefactive changes. 10) Endometritis: Chronic endometritis can cause discharge and infertility, but without fetal remnants.

The diagnostic algorithm for fetal maceration begins with a thorough history and physical examination. The presence of a vaginal discharge, especially with a foul odor, and a history of pregnancy loss should raise suspicion. Vaginal cytology may reveal neutrophils, bacteria, and possibly fetal bone fragments. Serum progesterone levels can help determine if the corpus luteum is still active; levels >2 ng/mL indicate luteal function. Complete blood count and biochemistry may show leukocytosis with a left shift, and elevated liver enzymes or azotemia if sepsis is present. Abdominal radiography can reveal fetal skeletal remnants, which are mineralized after day 45 of gestation in dogs and day 36 in cats. Ultrasonography is more sensitive and can show uterine fluid, fetal remnants, and the absence of fetal heartbeats. The uterine wall may be thickened. If the cervix is open, vaginoscopy may allow visualization of fetal bones. Bacterial culture of the vaginal discharge or uterine contents can identify the causative organism. In cases where the diagnosis is uncertain, exploratory laparotomy may be necessary. The diagnostic workup should also include screening for brucellosis in dogs, using serology or PCR.

Laboratory findings in fetal maceration often reflect systemic inflammation and possible sepsis. Hematology may show leukocytosis with a left shift, toxic neutrophils, and sometimes neutropenia in severe cases. Anemia may be present if there is chronic blood loss. Biochemistry may reveal elevated liver enzymes (ALT, AST) due to endotoxemia, and azotemia (elevated BUN and creatinine) if renal function is compromised. Hyperglobulinemia may be present due to chronic infection. Serum progesterone levels are typically elevated (>2 ng/mL) if the corpus luteum is still active, but may be low if luteolysis has occurred. Vaginal cytology may show a mixture of parabasal and intermediate cells, with numerous neutrophils and bacteria. The presence of fetal bone fragments in the discharge is diagnostic. Bacterial culture of the discharge may yield organisms such as E. coli, Streptococcus spp., or Brucella canis. In cats, viral testing for FeLV and FIV may be indicated. Urinalysis may show proteinuria or hematuria if there is systemic involvement.

Imaging is crucial for the diagnosis of fetal maceration. Abdominal radiography can demonstrate fetal skeletal remnants, which are mineralized after day 45 of gestation in dogs and day 36 in cats. The bones may appear as scattered, irregular opacities within the uterine silhouette. The uterus may be enlarged and have a tubular or sacculated appearance. Ultrasonography is more sensitive and can reveal the absence of fetal heartbeats, fetal death, and the presence of echogenic material within the uterine lumen. The uterine wall may be thickened, and the contents may have a mixed echogenicity due to fluid and bone fragments. In some cases, the fetal bones may cast acoustic shadows. Ultrasonography can also assess the ovaries for the presence of corpora lutea. CT and MRI are rarely used but can provide detailed images of the uterine contents and any complications such as uterine rupture. Vaginoscopy can be performed if the cervix is open, allowing direct visualization of fetal bones and discharge.

Vaginal cytology in fetal maceration typically shows a mixed inflammatory pattern with numerous neutrophils, macrophages, and bacteria. The presence of fetal bone fragments or squamous epithelial cells may be noted. Histopathology of the uterus, if obtained via biopsy or after ovariohysterectomy, reveals chronic endometritis with infiltration of neutrophils, lymphocytes, and plasma cells. The uterine glands may be dilated, and there may be fibrosis of the stroma. The presence of fetal bone fragments within the uterine lumen is characteristic. Special stains, such as Gram stain, can help identify bacterial organisms. In cases of brucellosis, the organism may be identified in uterine tissues using immunohistochemistry or PCR. Histopathology can also reveal the presence of cystic endometrial hyperplasia, which may be a predisposing factor.

Treatment of fetal maceration depends on the severity of the condition and the reproductive status of the animal. In cases where the animal is a valuable breeding animal and the condition is mild, medical management may be attempted. The goal is to evacuate the uterine contents and resolve the infection. Prostaglandin F2alpha (PGF2α) is used to induce luteolysis and uterine contraction. In dogs, dinoprost tromethamine is administered at a dose of 0.1-0.25 mg/kg SC, three times daily, or cloprostenol at 1-2.5 μg/kg SC, every 48 hours. In cats, PGF2α is used cautiously at lower doses. Cabergoline, a dopamine agonist, can be used to reduce progesterone levels by inhibiting prolactin, and is given at 5 μg/kg PO, once daily. Aglepristone, a progesterone receptor antagonist, can also be used to terminate pregnancy and promote cervical relaxation, at a dose of 10 mg/kg SC, twice, 24 hours apart. Oxytocin may be used to stimulate uterine contractions, but only after the cervix is open, at a dose of 0.5-2 IU/kg IM or IV. Antibiotics should be administered based on culture and sensitivity, but broad-spectrum antibiotics such as amoxicillin-clavulanate (12.5-25 mg/kg PO, q8-12h) or enrofloxacin (5-10 mg/kg PO, q24h) may be initiated. In severe cases, or if medical management fails, ovariohysterectomy is the treatment of choice, especially in non-breeding animals. Supportive care includes intravenous fluids, anti-inflammatory drugs, and nutritional support. In cases of sepsis, aggressive fluid therapy and systemic antibiotics are essential.

The prognosis for fetal maceration depends on the extent of uterine damage and the presence of systemic complications. With early diagnosis and appropriate medical management, the prognosis for survival is good, but the future fertility may be compromised. If the condition is associated with severe endometritis or pyometra, the prognosis for future breeding is poor, and ovariohysterectomy may be recommended. In cases of brucellosis, the prognosis for a successful pregnancy is guarded, and the animal should be removed from the breeding program. The prognosis is worse if there is uterine rupture or peritonitis. Negative prognostic indicators include severe systemic illness, prolonged duration of the condition, and the presence of multidrug-resistant bacteria. With surgical intervention, the prognosis for recovery is excellent, but the animal will be infertile.

Follow-up after treatment of fetal maceration is essential to ensure complete resolution and to monitor for complications. If medical management is used, serial ultrasonography should be performed every 3-5 days to assess uterine involution and the absence of fetal remnants. Serum progesterone levels should be monitored to ensure luteolysis has occurred. Vaginal cytology can be repeated to assess the resolution of inflammation. After ovariohysterectomy, the surgical incision should be monitored for healing, and the animal should be restricted from activity for 10-14 days. If the animal is intended for future breeding, a breeding soundness examination should be performed after the next estrous cycle, including vaginal cytology, progesterone assays, and uterine culture. In cases of brucellosis, serological testing should be repeated at 30-day intervals until negative. The owner should be advised to maintain good hygiene and biosecurity to prevent recurrence.

Clinical pearls: 1) Fetal maceration should be suspected in any pregnant female with a foul-smelling vaginal discharge and a history of fetal death. 2) Ultrasonography is the most sensitive diagnostic tool; the absence of fetal heartbeats and the presence of echogenic debris are key findings. 3) Prostaglandin F2α is effective in evacuating the uterus, but the cervix must be open; if closed, aglepristone can be used to relax it. 4) Antibiotic therapy should be based on culture and sensitivity, as resistance is common. 5) In cases of brucellosis, strict biosecurity measures are essential to prevent spread. Pitfalls: 1) Do not use oxytocin if the cervix is closed, as it can cause uterine rupture. 2) Avoid the use of corticosteroids, as they can exacerbate the infection. 3) Do not delay surgical intervention in cases of severe systemic illness, as sepsis can be fatal. 4) Failure to identify and treat underlying causes, such as brucellosis, can lead to recurrence. 5) Incomplete evacuation of fetal remnants can lead to chronic endometritis and infertility.

Current drug protocols for fetal maceration include: 1) Aglepristone (Alizin): 10 mg/kg SC, twice, 24 hours apart, to terminate pregnancy and promote cervical relaxation. 2) Prostaglandin F2α (Dinoprost tromethamine): 0.1-0.25 mg/kg SC, three times daily, for 2-3 days, or Cloprostenol: 1-2.5 μg/kg SC, every 48 hours, to induce luteolysis and uterine evacuation. 3) Cabergoline: 5 μg/kg PO, once daily, to reduce progesterone levels. 4) Oxytocin: 0.5-2 IU/kg IM or IV, only after cervical relaxation, to stimulate uterine contractions. 5) Antibiotics: Amoxicillin-clavulanate (12.5-25 mg/kg PO, q8-12h), Enrofloxacin (5-10 mg/kg PO, q24h), or Metronidazole (10-15 mg/kg PO, q12h) for anaerobic coverage. 6) Supportive care: Intravenous fluids (Lactated Ringer's solution at 60-90 mL/kg/day), anti-inflammatory drugs (e.g., meloxicam 0.1 mg/kg PO, q24h), and nutritional support. 7) In cases of sepsis, additional therapy with dopamine or norepinephrine may be required. All protocols should be adjusted based on the patient's condition and response to therapy.

Evidence-based literature on fetal maceration is limited, but several key studies and reviews provide guidance. In dogs, Brucella canis is a well-documented cause of fetal maceration, and serological screening is recommended in endemic areas (Carmichael, 1990). A study by Johnston et al. (2001) in Canine and Feline Theriogenology describes the pathophysiology and management of fetal maceration, emphasizing the use of PGF2α and aglepristone. In cats, viral causes such as feline herpesvirus have been associated with fetal death and maceration (Sykes, 2014). The BSAVA Manual of Small Animal Reproduction (England & von Heimendahl, 2010) provides practical guidelines for diagnosis and treatment. A retrospective study by Smith (2005) reported that ovariohysterectomy is the most effective treatment in severe cases, with a good prognosis for recovery. The use of aglepristone for medical management has been supported by studies showing successful evacuation of uterine contents in cases of fetal death (Fieni et al., 2006). Overall, the evidence supports a combination of medical and surgical approaches, with early intervention being critical for a favorable outcome.